Note: Ingredients listed on restricted chemical lists
EC/CAS
203-473-3/107-21-1
Name of the chemical
Ethane-1,2-diol
Concentration
90 - 100
EC/CAS
219-660-8/2492-26-4
Name of the chemical
2(3H)-Benzothiazolethione,sodium salt (1:1)
Concentration
0,1-<0
General Information
Version
1.0
Revision date
2021-05-25
Product name
Zerocol P-OAT
1.2.1 Relevant identified uses
Professional uses
supplier name
Other
Emergency telephone
+44 (0)1709 890099, +353 1 809 2566, 1 809 2166
Icons in SDS
Company Information
company name
Granville Oil & Chemicals Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
lab@granvilleoil.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H373
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS07 GHS08
Signal word
Warning
Contains
ethanediol; ethylene glycol
Hazard statements
H302 - Harmful if swallowed. H373 - May cause damage to organs (kidneys) through prolonged or repeated exposure (oral).
Precautionary statements
P260 - Do not breathe vapours, spray. P264 - Wash hands, forearms and face thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P301+P312 - IF SWALLOWED: Call a POISON CENTER, doctor if you feel unwell. P330 - Rinse mouth. P501 - Dispose of contents and container to an approved waste disposal plant.
Additional information
EUH208 - Contains sodium benzothiazol-2-yl sulphide. May produce an allergic reaction.
Results of PBT and vPvB assessment
Not applicable. The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Acute toxicity (oral), Category 4 H302 Specific target organ toxicity – Repeated exposure, H373 Category 2 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available 2.2. Label elements
